ArticleEndoscopic ultrasound
Optimal timing for hepatic cyst intervention: Predictive factors for complete resolution after ethanol sclerotherapy.
Article in Endoscopic ultrasound. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: The optimal timing of ethanol sclerotherapy and predictors of complete resolution (CR) in patients with symptomatic hepatic cysts remain unclear. This study aimed to identify clinical and procedural predictors of CR and to determine a volume-based threshold that may guide patient selection. Methods: We retrospectively analyzed 307 patients who underwent percutaneous catheter drainage-guided or EUS-guided ethanol sclerotherapy between 2003 and 2023. CR was defined as <5% of baseline cyst volume. Receiver operating characteristic analysis identified a volume threshold for CR, and multivariable logistic regression was used to determine independent predictors. Results: CR was achieved in 54.4% of patients during a mean follow-up of 24.7 ± 21.1 months. An initial cyst volume of 233 mL (≈7-8 cm in diameter) was identified by receiver operating characteristic analysis as a threshold associated with CR (area under the curve 0.626; sensitivity 50.9%; specificity 75.0%). CR rates were significantly higher in cysts <233 mL than in larger cysts (70.6% Conclusion: Initial hepatic cyst volume is an important factor influencing treatment outcome. The 233 mL threshold may inform the timing of intervention alongside symptoms and patient-specific factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.